메뉴 건너뛰기




Volumn 4, Issue 4, 2010, Pages 307-322

Neurofibromatosis type 1: Diagnosis and recent advances

Author keywords

Malignant peripheral nerve sheath tumours; Modifying genes; Molecular diagnosis; Mutation analysis; Neurofibromas; NF1; RASopathy; SPRED1

Indexed keywords

EVEROLIMUS; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMATINIB; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MEVINOLIN; NEUROFIBROMIN; PIRFENIDONE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN SHC; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAPAMYCIN;

EID: 77953929724     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2010.494660     Document Type: Review
Times cited : (36)

References (107)
  • 1
    • 12444334564 scopus 로고    scopus 로고
    • Prevalence of neurofibromatosis 1 in German children at elementary school enrollment
    • Lammert M, Friedman J, Kluwe L, et al. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005;141(1):71-74
    • (2005) Arch Dermatol , vol.141 , Issue.1 , pp. 71-74
    • Lammert, M.1    Friedman, J.2    Kluwe, L.3
  • 3
    • 65449184541 scopus 로고    scopus 로고
    • Neurofibromatosis type 1: Its association with the Ras/MAPK pathway syndromes
    • Bennett E, Thomas NS, Upadhyaya M. Neurofibromatosis type 1: its association with the Ras/MAPK pathway syndromes. J Paeditr Neurol 2009 7:1-5
    • (2009) J Paeditr Neurol , vol.7 , pp. 1-5
    • Bennett, E.1    Thomas, N.S.2    Upadhyaya, M.3
  • 4
    • 33847316896 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
    • Ferner R, Huson S, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81-88
    • (2007) J Med Genet , vol.44 , Issue.2 , pp. 81-88
    • Ferner, R.1    Huson, S.2    Thomas, N.3
  • 5
    • 0037442427 scopus 로고    scopus 로고
    • Progesterone receptor expression in neurofibromas
    • Mclaughlin M, Jacks T. Progesterone receptor expression in neurofibromas. Cancer Res 2003;63(4):752-755
    • (2003) Cancer Res , vol.63 , Issue.4 , pp. 752-755
    • McLaughlin, M.1    Jacks, T.2
  • 6
    • 62149143322 scopus 로고    scopus 로고
    • Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
    • Tucker T, Friedman JM, Friedrich RE, et al. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas. J Med Genet 2009;46:81-85
    • (2009) J Med Genet , vol.46 , pp. 81-85
    • Tucker, T.1    Friedman, J.M.2    Friedrich, R.E.3
  • 7
    • 33947530697 scopus 로고    scopus 로고
    • NF1 plexiformneurofibroma growth rate by volumetric MRI: Relationship to age and body weight
    • Dombi E, Solomon J, Gillespie A, et al. NF1 plexiformneurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology 2007;68(9):643-647
    • (2007) Neurology , vol.68 , Issue.9 , pp. 643-647
    • Dombi, E.1    Solomon, J.2    Gillespie, A.3
  • 8
    • 0036096489 scopus 로고    scopus 로고
    • Malignant peripheral nerve sheath tumours in neurofibromatosis 1
    • Evans D, Baser M, Mcgaughran J, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39(5):311-314
    • (2002) J Med Genet , vol.39 , Issue.5 , pp. 311-314
    • Evans, D.1    Baser, M.2    McGaughran, J.3
  • 9
    • 65349086151 scopus 로고    scopus 로고
    • Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
    • Brems H, Beert E, De Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009;10(5):508-515
    • (2009) Lancet Oncol , vol.10 , Issue.5 , pp. 508-515
    • Brems, H.1    Beert, E.2    De Ravel, T.3    Legius, E.4
  • 10
    • 84870227493 scopus 로고    scopus 로고
    • The neurofibromatosis: Classification, clinical features and genetic counselling
    • Kaufmann D, editor, Basel, Karger Monograph Hum Genet
    • Huson SM. The neurofibromatosis: classification, clinical features and genetic counselling. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger Monograph Hum Genet 2008;16:1-20
    • (2008) Neurofibromatoses , vol.16 , pp. 1-20
    • Huson, S.M.1
  • 11
  • 12
    • 34548328245 scopus 로고    scopus 로고
    • Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
    • Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007;39(9):1120-1126
    • (2007) Nat Genet , vol.39 , Issue.9 , pp. 1120-1126
    • Brems, H.1    Chmara, M.2    Sahbatou, M.3
  • 13
    • 50649111364 scopus 로고    scopus 로고
    • Constitutional mismatch repair-deficiency syndrome: Have we so far seen only the tip of an iceberg?
    • Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 2008;124(2):105-122
    • (2008) Hum Genet , vol.124 , Issue.2 , pp. 105-122
    • Wimmer, K.1    Etzler, J.2
  • 14
    • 29144462041 scopus 로고    scopus 로고
    • Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations
    • Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4(4):323-333
    • (2005) Fam Cancer , vol.4 , Issue.4 , pp. 323-333
    • Bandipalliam, P.1
  • 15
    • 34547796898 scopus 로고    scopus 로고
    • Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1
    • Maertens O, De Schepper S, Vandesompele J, et al. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 2007;81(2):243-251
    • (2007) Am J Hum Genet , vol.81 , Issue.2 , pp. 243-251
    • Maertens, O.1    De Schepper, S.2    Vandesompele, J.3
  • 16
    • 34547657613 scopus 로고    scopus 로고
    • The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1
    • Stevenson D, Viskochil D, Schorry E, et al. The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet Med 2007;9(7):409-412
    • (2007) Genet Med , vol.9 , Issue.7 , pp. 409-412
    • Stevenson, D.1    Viskochil, D.2    Schorry, E.3
  • 17
    • 0025369709 scopus 로고
    • Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
    • Viskochil D, Buchberg A, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62(1):187-192
    • (1990) Cell , vol.62 , Issue.1 , pp. 187-192
    • Viskochil, D.1    Buchberg, A.2    Xu, G.3
  • 18
    • 84870201398 scopus 로고    scopus 로고
    • NF1 gene structure and NF1 genotype/phenotype correlations
    • Kaufmann D, editor, Basel, Karger. MonogrHum Genet
    • Upadhyaya M. NF1 gene structure and NF1 genotype/phenotype correlations. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHum Genet 2008;16:46-62
    • (2008) Neurofibromatoses , vol.16 , pp. 46-62
    • Upadhyaya, M.1
  • 19
    • 0035936783 scopus 로고    scopus 로고
    • NF1 tumor suppressor gene function: Narrowing the GAP
    • Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104(4):593-604
    • (2001) Cell , vol.104 , Issue.4 , pp. 593-604
    • Cichowski, K.1    Jacks, T.2
  • 20
    • 33947429718 scopus 로고    scopus 로고
    • Neurofibromatosis
    • Mcclatchey A. Neurofibromatosis. Annu Rev Pathol 2007;2:191-216
    • (2007) Annu Rev Pathol , vol.2 , pp. 191-216
    • McClatchey, A.1
  • 21
    • 79959618575 scopus 로고    scopus 로고
    • Structure and function of neurofibromin
    • Kaufmann D, editor, Basel, Karger. MonogrHum Genet
    • Welti S, D'angelo I, Scheffzek. Structure and function of neurofibromin. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHum Genet 2008;16:46-62
    • (2008) Neurofibromatoses , vol.16 , pp. 46-62
    • Welti, S.1    D'Angelo, I.2    Scheffzek3
  • 22
    • 20844435467 scopus 로고    scopus 로고
    • The NF1 tumor suppressor critically regulates TSC2 and mTOR
    • Johannessen C, Reczek E, James M, et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci USA 2005;102(24):8573- 8578
    • (2005) Proc Natl Acad Sci USA , vol.102 , Issue.24 , pp. 8573-8578
    • Johannessen, C.1    Reczek, E.2    James, M.3
  • 24
    • 0002056513 scopus 로고    scopus 로고
    • The mutation spectrum in neurofibromatosis type 1 and its underlying mechanism
    • Chapter 5. In: Upadhyaya M, Cooper D, editors. BIOS Scientific, Oxford
    • Upadhyaya M, Cooper DN. The mutation spectrum in neurofibromatosis type 1 and its underlying mechanism. Chapter 5. In: Upadhyaya M, Cooper D, editors, Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific, Oxford; 1998. p. 65-87
    • (1998) Neurofibromatosis Type 1: From Genotype to Phenotype , pp. 65-87
    • Upadhyaya, M.1    Cooper, D.N.2
  • 25
    • 77953954245 scopus 로고    scopus 로고
    • Available from
    • Available from: http://www.hgmd.org
  • 26
    • 84870198562 scopus 로고    scopus 로고
    • NF1 Mutational spectrum
    • Kaufmann D, editor, Basel, Karger. MonogrHumGenet
    • Messiaen LM, Wimmer K. NF1 Mutational spectrum. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHumGenet 2008;16:63-77
    • (2008) Neurofibromatoses , vol.16 , pp. 63-77
    • Messiaen, L.M.1    Wimmer, K.2
  • 27
    • 1042299966 scopus 로고    scopus 로고
    • Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene
    • Kluwe L, Siebert R, Gesk S, et al. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 2004;23(2):111-116
    • (2004) Hum Mutat , vol.23 , Issue.2 , pp. 111-116
    • Kluwe, L.1    Siebert, R.2    Gesk, S.3
  • 28
    • 32544441269 scopus 로고    scopus 로고
    • Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients
    • Wimmer K, Yao S, Claes K, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 2006;45(3):265-276
    • (2006) Genes Chromosomes Cancer , vol.45 , Issue.3 , pp. 265-276
    • Wimmer, K.1    Yao, S.2    Claes, K.3
  • 29
    • 0033966774 scopus 로고    scopus 로고
    • Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
    • Ars E, Serra E, García J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000;9(2):237-247
    • (2000) Hum Mol Genet , vol.9 , Issue.2 , pp. 237-247
    • Ars, E.1    Serra, E.2    García, J.3
  • 30
    • 0028120348 scopus 로고
    • Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene
    • Upadhyaya M, Shaw D, Harper P. Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 1994;4(2):83-101
    • (1994) Hum Mutat , vol.4 , Issue.2 , pp. 83-101
    • Upadhyaya, M.1    Shaw, D.2    Harper, P.3
  • 31
    • 0038481667 scopus 로고    scopus 로고
    • Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients
    • Ars E, Kruyer H, Morell M, et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003;40(6):82
    • (2003) J Med Genet , vol.40 , Issue.6 , pp. 82
    • Ars, E.1    Kruyer, H.2    Morell, M.3
  • 32
    • 33847112447 scopus 로고    scopus 로고
    • Molecular diagnosis for NF1: 2 years experience
    • Griffiths S, Thompson P, Frayling I, et al. Molecular diagnosis for NF1: 2 years experience. Fam Cancer 2007;6(1):21-34
    • (2007) Fam Cancer , vol.6 , Issue.1 , pp. 21-34
    • Griffiths, S.1    Thompson, P.2    Frayling, I.3
  • 33
    • 0034267932 scopus 로고    scopus 로고
    • Segmental neurofibromatosis
    • Ruggieri M, Polizzi A. Segmental neurofibromatosis. J Neurosurg 2000;93(3):530-532
    • (2000) J Neurosurg , vol.93 , Issue.3 , pp. 530-532
    • Ruggieri, M.1    Polizzi, A.2
  • 34
    • 27144550883 scopus 로고    scopus 로고
    • Gonosomalmosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1
    • Consoli C, Moss C, Green S, et al. Gonosomalmosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125(3):463-466
    • (2005) J Invest Dermatol , vol.125 , Issue.3 , pp. 463-466
    • Consoli, C.1    Moss, C.2    Green, S.3
  • 35
    • 77953948637 scopus 로고    scopus 로고
    • Available from
    • Available from: http://www.dh.gov.uk/
  • 36
    • 26444532012 scopus 로고    scopus 로고
    • Preimplantation genetic diagnosis for neurofibromatosis type 1
    • Spits C, De Rycke M, Van Ranst N, et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. Mol Hum Reprod 2005;11(5):381-387
    • (2005) Mol Hum Reprod , vol.11 , Issue.5 , pp. 381-387
    • Spits, C.1    De Rycke, M.2    Van Ranst, N.3
  • 37
    • 0028082464 scopus 로고
    • Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients
    • Kayes L, Burke W, Riccardi V, et al. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 1994;54(3):424-436
    • (1994) Am J Hum Genet , vol.54 , Issue.3 , pp. 424-436
    • Kayes, L.1    Burke, W.2    Riccardi, V.3
  • 38
    • 0031744843 scopus 로고    scopus 로고
    • Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay
    • Upadhyaya M, Ruggieri M, Maynard J, et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998;102:591-597
    • (1998) Hum Genet , vol.102 , pp. 591-597
    • Upadhyaya, M.1    Ruggieri, M.2    Maynard, J.3
  • 39
    • 33845974480 scopus 로고    scopus 로고
    • An absence of cutaneousneurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation
    • Upadhyaya M, Huson S, Davies M, et al. An absence of cutaneousneurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007;80(1):140-151
    • (2007) Am J Hum Genet , vol.80 , Issue.1 , pp. 140-151
    • Upadhyaya, M.1    Huson, S.2    Davies, M.3
  • 40
    • 39749145210 scopus 로고    scopus 로고
    • NF1 microduplication first clinical report: Association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?
    • Grisart B, Rack K, Vidrequin S, et al. NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia? Eur J Hum Genet 2008;16(3):305-311
    • (2008) Eur J Hum Genet , vol.16 , Issue.3 , pp. 305-311
    • Grisart, B.1    Rack, K.2    Vidrequin, S.3
  • 41
    • 0037562897 scopus 로고    scopus 로고
    • NF1 mutations and clinical spectrum in patients with spinal neurofibromas
    • Kluwe L, Tatagiba M, Fünsterer C, Mautner V. NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J Med Genet 2003;40(5):368-371
    • (2003) J Med Genet , vol.40 , Issue.5 , pp. 368-371
    • Kluwe, L.1    Tatagiba, M.2    Fünsterer, C.3    Mautner, V.4
  • 42
    • 70249117521 scopus 로고    scopus 로고
    • The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas
    • Upadhyaya M, Spurlock G, Kluwe L, et al. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics 2009;10(3):251-263
    • (2009) Neurogenetics , vol.10 , Issue.3 , pp. 251-263
    • Upadhyaya, M.1    Spurlock, G.2    Kluwe, L.3
  • 43
    • 61849107166 scopus 로고    scopus 로고
    • A severe form of Noonan syndrome and autosomal dominant cafe-au-lait spots - Evidence for different genetic origins
    • Nystrom A, Ekvall S, Stromberg B, et al. A severe form of Noonan syndrome and autosomal dominant cafe-au-lait spots - evidence for different genetic origins. Acta Paediatr 2009;98(4):693-698
    • (2009) Acta Paediatr , vol.98 , Issue.4 , pp. 693-698
    • Nystrom, A.1    Ekvall, S.2    Stromberg, B.3
  • 44
    • 0027379865 scopus 로고
    • An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes
    • Easton D, Ponder M, Huson S, Ponder B. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993;53(2):305-313
    • (1993) Am J Hum Genet , vol.53 , Issue.2 , pp. 305-313
    • Easton, D.1    Ponder, M.2    Huson, S.3    Ponder, B.4
  • 45
    • 33847613982 scopus 로고    scopus 로고
    • Nf1 expression is dependent on strain background: Implications for tumor suppressor haploinsufficiency studies
    • Hawes J, Tuskan R, Reilly K. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics. 2007;8(2):121-130
    • (2007) Neurogenetics , vol.8 , Issue.2 , pp. 121-130
    • Hawes, J.1    Tuskan, R.2    Reilly, K.3
  • 46
    • 71749103918 scopus 로고    scopus 로고
    • Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome
    • Messiaen L, Yao S, Brems H, et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 2009;302(19):2111-2118
    • (2009) JAMA , vol.302 , Issue.19 , pp. 2111-2118
    • Messiaen, L.1    Yao, S.2    Brems, H.3
  • 47
    • 58149375379 scopus 로고    scopus 로고
    • Spred1 is required for synaptic plasticity and hippocampus-dependent learning
    • Denayer E, Ahmed T, Brems H, et al. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci 2008;28(53):14443- 14449
    • (2008) J Neurosci , vol.28 , Issue.53 , pp. 14443-14449
    • Denayer, E.1    Ahmed, T.2    Brems, H.3
  • 48
    • 67650489624 scopus 로고    scopus 로고
    • SPRED1 mutations (Legius syndrome): Another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype
    • Spurlock G, Bennett E, Chuzhanova N, et al. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 2009;46(7):431-437
    • (2009) J Med Genet , vol.46 , Issue.7 , pp. 431-437
    • Spurlock, G.1    Bennett, E.2    Chuzhanova, N.3
  • 49
    • 67650470276 scopus 로고    scopus 로고
    • SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype
    • Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009;46(7):425-430
    • (2009) J Med Genet , vol.46 , Issue.7 , pp. 425-430
    • Pasmant, E.1    Sabbagh, A.2    Hanna, N.3
  • 50
    • 56049088767 scopus 로고    scopus 로고
    • Clinical and molecular aspects of RAS related disorders
    • Denayer E, De Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet 2008;45(11):695-703
    • (2008) J Med Genet , vol.45 , Issue.11 , pp. 695-703
    • Denayer, E.1    De Ravel, T.2    Legius, E.3
  • 51
    • 33947594129 scopus 로고    scopus 로고
    • Hyperactive Ras in developmental disorders and cancer
    • Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer, Nat Rev Cancer 2007;7:295-308
    • (2007) Nat Rev Cancer , vol.7 , pp. 295-308
    • Schubbert, S.1    Shannon, K.2    Bollag, G.3
  • 52
    • 75149112680 scopus 로고    scopus 로고
    • Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back
    • Rauen K, Schoyer L, Mccormick F, et al. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: from bedside to bench and back. Am J Med Genet A 2010;152A(1):4-24
    • (2010) Am J Med Genet A , vol.152 A , Issue.1 , pp. 4-24
    • Rauen, K.1    Schoyer, L.2    McCormick, F.3
  • 53
    • 0016720617 scopus 로고
    • The reaction of connective tissue fibers in the tumor of Recklinghausen's disease
    • Lassmann H, Gebhart W, Stockinger L. The reaction of connective tissue fibers in the tumor of Recklinghausen's disease. Virchows Arch B Cell Pathol 1975;19(2):167-177
    • (1975) Virchows Arch B Cell Pathol , vol.19 , Issue.2 , pp. 167-177
    • Lassmann, H.1    Gebhart, W.2    Stockinger, L.3
  • 54
    • 0024205976 scopus 로고
    • Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis
    • Peltonen J, Jaakkola S, Lebwohl M, et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988;59(6):760-771
    • (1988) Lab Invest , vol.59 , Issue.6 , pp. 760-771
    • Peltonen, J.1    Jaakkola, S.2    Lebwohl, M.3
  • 55
    • 30044443915 scopus 로고    scopus 로고
    • Tight junction proteins and perineurial cells in neurofibromas
    • Pummi K, Aho H, Laato M, et al. Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem 2006;54(1):53-61
    • (2006) J Histochem Cytochem , vol.54 , Issue.1 , pp. 53-61
    • Pummi, K.1    Aho, H.2    Laato, M.3
  • 56
    • 0034642298 scopus 로고    scopus 로고
    • Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations
    • Serra E, Rosenbaum T, Winner U, et al. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000;9(20):3055-3064
    • (2000) Hum Mol Genet , vol.9 , Issue.20 , pp. 3055-3064
    • Serra, E.1    Rosenbaum, T.2    Winner, U.3
  • 57
    • 0015043748 scopus 로고
    • Mutation and cancer: Statistical study of retinoblastoma
    • Knudson AJ. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68(4):820-823
    • (1971) Proc Natl Acad Sci USA , vol.68 , Issue.4 , pp. 820-823
    • Knudson, A.J.1
  • 58
    • 10744220011 scopus 로고    scopus 로고
    • Characterisation of somatic mutational spectrum of neurofibromatosis type (NF1) gene in neurofibromatosis patients with benign and malignant tumours
    • Upadhyaya M, Han S, Consoli C, Majounie E, et al. Characterisation of somatic mutational spectrum of neurofibromatosis type (NF1) gene in neurofibromatosis patients with benign and malignant tumours. Hum Mut 2004;23:134-146
    • (2004) Hum Mut , vol.23 , pp. 134-146
    • Upadhyaya, M.1    Han, S.2    Consoli, C.3    Majounie, E.4
  • 59
    • 38149064478 scopus 로고    scopus 로고
    • Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)
    • Upadhyaya M, Kluwe L, Spurlock G, et al. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat 2008;29(1):74-82
    • (2008) Hum Mutat , vol.29 , Issue.1 , pp. 74-82
    • Upadhyaya, M.1    Kluwe, L.2    Spurlock, G.3
  • 60
    • 0033864837 scopus 로고    scopus 로고
    • Loss of NF1 gene expression in NF1-associated pilocyticastrocytomas
    • Gutmann DH, Donahoe J, Brown T, et al. Loss of NF1 gene expression in NF1-associated pilocyticastrocytomas. Neuropathol Appl Neurobiol 2000;26:361-367
    • (2000) Neuropathol Appl Neurobiol , vol.26 , pp. 361-367
    • Gutmann, D.H.1    Donahoe, J.2    Brown, T.3
  • 61
    • 34447114512 scopus 로고    scopus 로고
    • Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1
    • Bausch B, Borozdin W, Mautner V, et al. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 2007;92(7):2784-2792
    • (2007) J Clin Endocrinol Metab , vol.92 , Issue.7 , pp. 2784-2792
    • Bausch, B.1    Borozdin, W.2    Mautner, V.3
  • 62
    • 0030947237 scopus 로고    scopus 로고
    • Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
    • Side L, Taylor B, Cayouette M, et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997;336(24):1713-1720
    • (1997) N Engl J Med , vol.336 , Issue.24 , pp. 1713-1720
    • Side, L.1    Taylor, B.2    Cayouette, M.3
  • 63
    • 33644781795 scopus 로고    scopus 로고
    • Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
    • Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006;15(6):1015-1023
    • (2006) Hum Mol Genet , vol.15 , Issue.6 , pp. 1015-1023
    • Maertens, O.1    Prenen, H.2    Debiec-Rychter, M.3
  • 64
    • 33847168544 scopus 로고    scopus 로고
    • Gastric carcinoid: Germline and somatic mutation of the neurofibromatosis type 1 gene
    • Stewart W, Traynor J, Cooke A, et al. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Fam Cancer 2007;6(1):147-152
    • (2007) Fam Cancer , vol.6 , Issue.1 , pp. 147-152
    • Stewart, W.1    Traynor, J.2    Cooke, A.3
  • 65
    • 70349743969 scopus 로고    scopus 로고
    • Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association
    • Brems H, Park C, Maertens O, et al. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 2009;69(18):7393-7401
    • (2009) Cancer Res , vol.69 , Issue.18 , pp. 7393-7401
    • Brems, H.1    Park, C.2    Maertens, O.3
  • 66
    • 33745259022 scopus 로고    scopus 로고
    • Double inactivation of NF1 in tibialpseudarthrosis
    • Stevenson D, Zhou H, Ashrafi S, et al. Double inactivation of NF1 in tibialpseudarthrosis. Am J Hum Genet 2006;79(1):143-148
    • (2006) Am J Hum Genet , vol.79 , Issue.1 , pp. 143-148
    • Stevenson, D.1    Zhou, H.2    Ashrafi, S.3
  • 67
    • 0037012848 scopus 로고    scopus 로고
    • Neurofibromas in NF1: Schwann cell origin and role of tumor environment
    • Zhu Y, Ghosh P, Charnay P, et al. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002;296(5569):920-922
    • (2002) Science , vol.296 , Issue.5569 , pp. 920-922
    • Zhu, Y.1    Ghosh, P.2    Charnay, P.3
  • 68
    • 54549095884 scopus 로고    scopus 로고
    • Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow
    • Yang F, Ingram D, Chen S, et al. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 2008;135(3):437-448
    • (2008) Cell , vol.135 , Issue.3 , pp. 437-448
    • Yang, F.1    Ingram, D.2    Chen, S.3
  • 69
    • 57749101397 scopus 로고    scopus 로고
    • NF1 loss disrupts Schwann cell-axonal interactions: A novel role for semaphorin 4F
    • Parrinello S, Noon L, Harrisingh M, et al. NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F. Genes Dev 2008;22(23):3335-3348
    • (2008) Genes Dev , vol.22 , Issue.23 , pp. 3335-3348
    • Parrinello, S.1    Noon, L.2    Harrisingh, M.3
  • 70
    • 65349141187 scopus 로고    scopus 로고
    • Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas
    • Le L, Shipman T, Burns D, Parada L. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 2009;4(5):453-463
    • (2009) Cell Stem Cell , vol.4 , Issue.5 , pp. 453-463
    • Le, L.1    Shipman, T.2    Burns, D.3    Parada, L.4
  • 71
    • 38549102668 scopus 로고    scopus 로고
    • The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells
    • Joseph N, Mosher J, Buchstaller J, et al. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 2008;13(2):129-140
    • (2008) Cancer Cell , vol.13 , Issue.2 , pp. 129-140
    • Joseph, N.1    Mosher, J.2    Buchstaller, J.3
  • 72
    • 78649329027 scopus 로고    scopus 로고
    • Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: Correlation between histopathological, clinical and molecular findings
    • In press
    • Spurlock G, Knight S, Thomas NICK, et al. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings J Cancer Res Clin Oncol 2010; In press
    • (2010) J Cancer Res Clin Oncol
    • Spurlock, G.1    Knight, S.2    Thomas, N.I.C.K.3
  • 73
    • 39749203515 scopus 로고    scopus 로고
    • High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization
    • Mantripragada K, Spurlock G, Kluwe L, et al. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res 2008;14(4):1015-1024
    • (2008) Clin Cancer Res , vol.14 , Issue.4 , pp. 1015-1024
    • Mantripragada, K.1    Spurlock, G.2    Kluwe, L.3
  • 74
    • 70349307184 scopus 로고    scopus 로고
    • Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array
    • Mantripragada K, De Stahl T, Patridge C, et al. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes Chromosomes Cancer 2009;48(10):897-907
    • (2009) Genes Chromosomes Cancer , vol.48 , Issue.10 , pp. 897-907
    • Mantripragada, K.1    De Stahl, T.2    Patridge, C.3
  • 75
    • 1842610572 scopus 로고    scopus 로고
    • Recent advances in neurofibromatosis type 1
    • Arun D, Gutmann D. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004;17(2):101-105
    • (2004) Curr Opin Neurol , vol.17 , Issue.2 , pp. 101-105
    • Arun, D.1    Gutmann, D.2
  • 76
    • 30144442616 scopus 로고    scopus 로고
    • Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications
    • Gottfried O, Viskochil D, Fults D, Couldwell W. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 2006;58(1):1-16
    • (2006) Neurosurgery , vol.58 , Issue.1 , pp. 1-16
    • Gottfried, O.1    Viskochil, D.2    Fults, D.3    Couldwell, W.4
  • 77
    • 73349118491 scopus 로고    scopus 로고
    • PTEN dosage is essential for neurofibroma development and malignant transformation
    • Gregorian C, Nakashima J, Dry S, et al. PTEN dosage is essential for neurofibroma development and malignant transformation. Proc Natl Acad Sci USA 2009;106(46):19479-19484
    • (2009) Proc Natl Acad Sci USA , vol.106 , Issue.46 , pp. 19479-19484
    • Gregorian, C.1    Nakashima, J.2    Dry, S.3
  • 78
    • 0346059618 scopus 로고    scopus 로고
    • Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity
    • Bajenaru M, Hernandez M, Perry A, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 2003;63(24):8573-8577
    • (2003) Cancer Res , vol.63 , Issue.24 , pp. 8573-8577
    • Bajenaru, M.1    Hernandez, M.2    Perry, A.3
  • 79
    • 57849109837 scopus 로고    scopus 로고
    • Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model
    • Alcantara Llaguno S, Chen J, Kwon C, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15(1):45-56
    • (2009) Cancer Cell , vol.15 , Issue.1 , pp. 45-56
    • Alcantara Llaguno, S.1    Chen, J.2    Kwon, C.3
  • 80
    • 44849089702 scopus 로고    scopus 로고
    • Ptenhaploinsufficiency accelerates formation of high-grade astrocytomas
    • Kwon C, Zhao D, Chen J, et al. Ptenhaploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008;68(9):3286-3294
    • (2008) Cancer Res , vol.68 , Issue.9 , pp. 3286-3294
    • Kwon, C.1    Zhao, D.2    Chen, J.3
  • 82
    • 33645524364 scopus 로고    scopus 로고
    • Harnessing preclinical mouse models to inform human clinical cancer trials
    • Gutmann D, Hunter-Schaedle K, Shannon K. Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest 2006;116(4):847-852
    • (2006) J Clin Invest , vol.116 , Issue.4 , pp. 847-852
    • Gutmann, D.1    Hunter-Schaedle, K.2    Shannon, K.3
  • 83
    • 27644517404 scopus 로고    scopus 로고
    • The HMG-CoAreductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
    • Li W, Cui Y, Kushner S, et al. The HMG-CoAreductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005;15(21):1961-1967
    • (2005) Curr Biol , vol.15 , Issue.21 , pp. 1961-1967
    • Li, W.1    Cui, Y.2    Kushner, S.3
  • 84
    • 47549111338 scopus 로고    scopus 로고
    • Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial
    • Krab L, De Goede-Bolder A, Aarsen F, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300(3):287-294
    • (2008) JAMA , vol.300 , Issue.3 , pp. 287-294
    • Krab, L.1    De Goede-Bolder, A.2    Aarsen, F.3
  • 85
    • 49949110162 scopus 로고    scopus 로고
    • Modelling neurofibromatosis type 1 tibialdysplasia and its treatment with lovastatin
    • Kolanczyk M, Kuhnisch J, Kossler N, et al. Modelling neurofibromatosis type 1 tibialdysplasia and its treatment with lovastatin. BMC Med 2008;6:21
    • (2008) BMC Med , vol.6 , pp. 21
    • Kolanczyk, M.1    Kuhnisch, J.2    Kossler, N.3
  • 86
    • 70349498475 scopus 로고    scopus 로고
    • Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options
    • Elefteriou F, Kolanczyk M, Schindeler A, et al. Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A 2009;149A(10):2327-2338
    • (2009) Am J Med Genet A , vol.149 A , Issue.10 , pp. 2327-2338
    • Elefteriou, F.1    Kolanczyk, M.2    Schindeler, A.3
  • 87
    • 44449093081 scopus 로고    scopus 로고
    • TORC1 is essential for NF1-associated malignancies
    • Johannessen C, Johnson B, Williams S, et al. TORC1 is essential for NF1-associated malignancies. Curr Biol 2008;18(1):56-62
    • (2008) Curr Biol , vol.18 , Issue.1 , pp. 56-62
    • Johannessen, C.1    Johnson, B.2    Williams, S.3
  • 88
    • 77952668952 scopus 로고    scopus 로고
    • RNA splicing meets genetic testing: Detection and interpretation of splicing defects in genetic diseases
    • In press
    • Tosi M, Stamm S, Baralle D. RNA splicing meets genetic testing: detection and interpretation of splicing defects in genetic diseases. Eur J Hum Genet 2010; In press
    • (2010) Eur J Hum Genet
    • Tosi, M.1    Stamm, S.2    Baralle, D.3
  • 89
    • 34548136083 scopus 로고    scopus 로고
    • Detection of copy number changes at the NF1 locus with improved high-resolution array CGH
    • Shen M, Mantripragada K, Dumanski J, et al. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH. Clin Genet 2007;72(3):238-244
    • (2007) Clin Genet , vol.72 , Issue.3 , pp. 238-244
    • Shen, M.1    Mantripragada, K.2    Dumanski, J.3
  • 90
    • 70350452927 scopus 로고    scopus 로고
    • Detection and characterization of NF1 microdeletions by custom high resolution array CGH
    • Pasmant E, Sabbagh A, Masliah-Planchon J, et al. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn 2009;11(6):524-529
    • (2009) J Mol Diagn , vol.11 , Issue.6 , pp. 524-529
    • Pasmant, E.1    Sabbagh, A.2    Masliah-Planchon, J.3
  • 91
    • 52949096084 scopus 로고    scopus 로고
    • Next-generation DNA sequencing methods
    • Mardis E. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008;9:387-402
    • (2008) Annu Rev Genomics Hum Genet , vol.9 , pp. 387-402
    • Mardis, E.1
  • 92
    • 73449142861 scopus 로고    scopus 로고
    • DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model
    • Chou L, Liu C, Boese B, et al. DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model. Clin Chem 2010;56(1):62-72
    • (2010) Clin Chem , vol.56 , Issue.1 , pp. 62-72
    • Chou, L.1    Liu, C.2    Boese, B.3
  • 93
    • 52949127312 scopus 로고    scopus 로고
    • An integrated genomic analysis of human glioblastomamultiforme
    • Parsons D, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastomamultiforme. Science 2008;321(5897):1807-1812
    • (2008) Science , vol.321 , Issue.5897 , pp. 1807-1812
    • Parsons, D.1    Jones, S.2    Zhang, X.3
  • 94
    • 54549094903 scopus 로고    scopus 로고
    • Somatic mutations affect key pathways in lung adenocarcinoma
    • Ding L, Getz G, Wheeler D, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455(7216):1069-1075
    • (2008) Nature , vol.455 , Issue.7216 , pp. 1069-1075
    • Ding, L.1    Getz, G.2    Wheeler, D.3
  • 95
    • 57349132432 scopus 로고    scopus 로고
    • Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations
    • Sangha N, Wu R, Kuick R, et al. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia 2008;10(12):1362-1372
    • (2008) Neoplasia , vol.10 , Issue.12 , pp. 1362-1372
    • Sangha, N.1    Wu, R.2    Kuick, R.3
  • 96
    • 77952420655 scopus 로고    scopus 로고
    • AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
    • Haferlach C, Dicker F, Kohlmann A, et al. AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions. Leukemia 2010;24:1065-1069
    • (2010) Leukemia , vol.24 , pp. 1065-1069
    • Haferlach, C.1    Dicker, F.2    Kohlmann, A.3
  • 97
    • 33645061486 scopus 로고    scopus 로고
    • Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues
    • Miller S, Rangwala F, Williams J, et al. Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res 2006;66:2584-2591
    • (2006) Cancer Res , vol.66 , pp. 2584-2591
    • Miller, S.1    Rangwala, F.2    Williams, J.3
  • 98
    • 33746895189 scopus 로고    scopus 로고
    • Identification of a novel amplicon at distal 17q containing the BIRC5/ SURVIVIN gene in malignant peripheral nerve sheath tumours
    • Storlazzi C, Brekke H, Mandahl N, et al. Identification of a novel amplicon at distal 17q containing the BIRC5/ SURVIVIN gene in malignant peripheral nerve sheath tumours. J Pathol 2006;209(4):492-500
    • (2006) J Pathol , vol.209 , Issue.4 , pp. 492-500
    • Storlazzi, C.1    Brekke, H.2    Mandahl, N.3
  • 99
    • 67650095150 scopus 로고    scopus 로고
    • Ral overactivation in malignant peripheral nerve sheath tumors
    • Bodempudi V, Yamoutpoor F, Pan W, et al. Ral overactivation in malignant peripheral nerve sheath tumors. Mol Cell Biol 2009;29(14):3964-3974
    • (2009) Mol Cell Biol , vol.29 , Issue.14 , pp. 3964-3974
    • Bodempudi, V.1    Yamoutpoor, F.2    Pan, W.3
  • 100
    • 47349087197 scopus 로고    scopus 로고
    • DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
    • Kresse S, Skarn M, Ohnstad H, et al. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. Mol Cancer 2008;7:48
    • (2008) Mol Cancer , vol.7 , pp. 48
    • Kresse, S.1    Skarn, M.2    Ohnstad, H.3
  • 101
    • 75449103584 scopus 로고    scopus 로고
    • Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
    • Miller S, Jessen W, Mehta T, et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med 2009;1(4):236-248
    • (2009) EMBO Mol Med , vol.1 , Issue.4 , pp. 236-248
    • Miller, S.1    Jessen, W.2    Mehta, T.3
  • 102
    • 34047096557 scopus 로고    scopus 로고
    • Cancer stem cells: Models and concepts
    • DOI 10.1146/annurev.med.58.062105.204854
    • Dalerba P, Cho R, Clarke M. Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284 (Pubitemid 46706514)
    • (2007) Annual Review of Medicine , vol.58 , pp. 267-284
    • Dalerba, P.1    Cho, R.W.2    Clarke, M.F.3
  • 103
    • 41149100145 scopus 로고    scopus 로고
    • MicroRNA expression signature of human sarcomas
    • Subramanian S, Lui W, Lee C, et al. MicroRNA expression signature of human sarcomas. Oncogene 2008;27(14):2015-2026
    • (2008) Oncogene , vol.27 , Issue.14 , pp. 2015-2026
    • Subramanian, S.1    Lui, W.2    Lee, C.3
  • 104
    • 73649129263 scopus 로고    scopus 로고
    • Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
    • Subramanian S, Thayanithy V, West R, et al. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol 2010;220(1):58-70
    • (2010) J Pathol , vol.220 , Issue.1 , pp. 58-70
    • Subramanian, S.1    Thayanithy, V.2    West, R.3
  • 105
    • 64649097659 scopus 로고    scopus 로고
    • [18F] FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1
    • Warbey V, Ferner R, Dunn J, et al. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 2009;36(5):751-757
    • (2009) Eur J Nucl Med Mol Imaging , vol.36 , Issue.5 , pp. 751-757
    • Warbey, V.1    Ferner, R.2    Dunn, J.3
  • 106
    • 61649121051 scopus 로고    scopus 로고
    • Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations
    • Pros E, Fernandez-Rodriguez J, Canet B, et al. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Hum Mutat 2009;30(3):454-462
    • (2009) Hum Mutat , vol.30 , Issue.3 , pp. 454-462
    • Pros, E.1    Fernandez-Rodriguez, J.2    Canet, B.3
  • 107
    • 65849111219 scopus 로고    scopus 로고
    • Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
    • Scholl C, Frohling S, Dunn I, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009;137(5):821-834
    • (2009) Cell , vol.137 , Issue.5 , pp. 821-834
    • Scholl, C.1    Frohling, S.2    Dunn, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.